Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Oxidative Medicine and Cellular Longevity|August 10, 2019
Activators and Inhibitors of NRF2: A Review of Their Potential for Clinical DevelopmentNatalia Robledinos-Antón, Raquel Fernández-Ginés, Gina Manda, et al.
Cells|October 7, 2020
TAZ Represses the Neuronal Commitment of Neural Stem CellsNatalia Robledinos-Antón, Maribel Escoll, Kun-Liang Guan, et al.
Antioxidants (Basel, Switzerland)|August 23, 2020
WIP Modulates Oxidative Stress through NRF2/KEAP1 in Glioblastoma CellsMaribel Escoll, Diego Lastra, Natalia Robledinos-Antón, et al.
Redox Biology|July 2, 2017
Transcription factor NRF2 controls the fate of neural stem cells in the subgranular zone of the hippocampusNatalia Robledinos-Antón, Ana I Rojo, Elisabete Ferreiro, et al.
Journal of Medical Economics|January 16, 2023
Adopting a portfolio of ultrasonic and advanced bipolar electrosurgery devices from a single manufacturer compared to currently used ultrasonic and advanced bipolar devices: a probabilistic budget impact analysis from a Spanish hospital perspectiveAlessandra Piemontese, Lucas Cohen, George W J Wright, et al.
Scientific Reports|September 27, 2019
NRF2-dependent gene expression promotes ciliogenesis and Hedgehog signalingAna Martin-Hurtado, Raquel Martin-Morales, Natalia Robledinos-Antón, et al.
Redox Biology|January 10, 2020
Transcription factor NRF2 uses the Hippo pathway effector TAZ to induce tumorigenesis in glioblastomasMaribel Escoll, Diego Lastra, Marta Pajares, et al.
Redox Biology|June 3, 2017
Decreased neural precursor cell pool in NADPH oxidase 2-deficiency: From mouse brain to neural differentiation of patient derived iPSCZeynab Nayernia, Marilena Colaianna, Natalia Robledinos-Antón, et al.
Pharmacological Reviews|March 7, 2018
Transcription Factor NRF2 as a Therapeutic Target for Chronic Diseases: A Systems Medicine ApproachAntonio Cuadrado, Gina Manda, Ahmed Hassan, et al.
Redox Biology|June 4, 2017
European contribution to the study of ROS: A summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS)Javier Egea, Isabel Fabregat, Yves M Frapart, et al.
Pageof 1